Clinical Trials Browser

pexidartinib × Sarcoma × 1 year × Clear all

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Sarcoma, Neurofibrosarcoma